Can macrocytosis and increased RDW indicate functional B12 or folate strain despite normal serum B12 and folate levels?

Standard serum vitamin B12 and folate measurements can sometimes overlook intracellular, tissue-level deficiencies, masking a functional strain on one-carbon metabolism.

Clinical and hematological evidence

• Macrocytosis (elevated MCV): Functional, tissue-level B12 or folate deficiency impairs DNA synthesis in erythroid precursors, leading to macrocytosis. This hematological manifestation can occur even when circulating blood serum concentrations of B12 and folate are within normal reference ranges.
• Anisocytosis (increased RDW): Disrupted erythropoiesis prevents uniform red blood cell development, resulting in variations in cell size. This manifests clinically as an increased red cell distribution width (RDW). Notably, a rising RDW frequently serves as an early indicator of evolving intracellular deficiency, often preceding overt elevations in MCV.

Mechanistic pathways

• Intracellular metabolic blocks: When B12- or folate-dependent intracellular pathways are strained, the cells cannot utilize these vitamins effectively, despite adequate serum levels.
• Metabolite accumulation: This block impairs key enzymatic steps, leading to the accumulation of metabolic intermediates. Specifically, impaired B12-dependent pathways lead to intracellular accumulation of methylmalonyl-CoA, elevating methylmalonic acid (MMA) in the blood or urine.
• Elevated homocysteine: The remethylation of homocysteine to methionine requires both B12 and folate as essential cofactors. Impairment in this pathway leads to systemic elevations of homocysteine, serving as a functional marker of one-carbon metabolism strain.

Bottom line

• Normal serum B12 and folate levels do not exclude tissue-level deficiency. Elevated MCV and a rising RDW—accompanied by elevations in MMA and homocysteine—are highly sensitive markers of functional, intracellular one-carbon metabolism strain.